Skip to Main Content

Paper Details

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.
bioRxiv
12
2020
-, ACE2, ACE2 receptor, ACE2 variants, RBD, SARS, SARS-, SARS-CoV, SARS-CoV-, SARS-CoV-2, amino acid, angiotensin-converting enzyme II, cells, collectrin domain, entry receptors, host cells, human, human Fc domain, patients, viral spike protein, wild-type ACE2, yeast
Author NameAffiliation
Irene LuiDepartment of Pharmaceutical Chemistry, University of California at San Francisco
Oren S RosenbergUniversity of California at San Francisco
Arun P WiitaUniversity of California at San Francisco
Arun P WiitaUniversity of California at San Francisco
Tanja KortemmeUniversity of California at San Francisco
James A WellsDepartment of Pharmaceutical Chemistry, University of California at San Francisco
James A WellsUniversity of California at San Francisco
  • 1 - 7

Datasets

Release 1.2